41717-32-2 Usage
Uses
Used in Pharmaceutical Industry:
2-CyanoBenzofuran is used as a key intermediate in the synthesis of imidazoline I1 and I2 selective ligands for the imidazoline and α-adrenergic receptors. These ligands play a crucial role in the development of drugs targeting these receptors, which are involved in various physiological processes, including blood pressure regulation, pain modulation, and neuroprotection.
Used in Antiparasitic and Antifungal Agents:
2-CyanoBenzofuran is also utilized in the synthesis of antiparasitic and antifungal arylthiazolines. These compounds exhibit potent activity against a wide range of parasites and fungi, making them valuable in the development of treatments for parasitic and fungal infections.
Check Digit Verification of cas no
The CAS Registry Mumber 41717-32-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,7,1 and 7 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 41717-32:
(7*4)+(6*1)+(5*7)+(4*1)+(3*7)+(2*3)+(1*2)=102
102 % 10 = 2
So 41717-32-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H5NO/c10-6-8-5-7-3-1-2-4-9(7)11-8/h1-5H
41717-32-2Relevant academic research and scientific papers
Iridium-catalyzed hydrogen transfer: Synthesis of substituted benzofurans, benzothiophenes, and indoles from benzyl alcohols
Anxionnat, Bruno,Gomez Pardo, Domingo,Ricci, Gino,Rossen, Kai,Cossy, Janine
supporting information, p. 3876 - 3879 (2013/09/02)
An iridium-catalyzed hydrogen transfer has been developed in the presence of p-benzoquinone, allowing the synthesis of a diversity of substituted benzofurans, benzothiophenes, and indoles from substituted benzylic alcohols.
Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase
-
, (2008/06/13)
Compounds of formula (I) STR1where R 1 is hydrogen; R 2 is nitro, cyano or halo(lower)alkyl; R 3 is phenyl substituted with one or more substituents selected from halogen, cyano and lower alkoxy; A is a lower alkylene group; R 4 is a group CR 6 R 7 R 8 wherein R 6 and R 7 form, together with the carbon atom to which they are attached a cycloalkyl group optionally substituted with hydroxy, lower alkoxy or a lower alkanoylamino; and R 8 is hydrogen; its prodrug and a salt thereof.
